Optical coherence tomography biomarkers in preterm infants with and without retinopathy of prematurity: fallacies and facts

Belenje A, Reddy RU, Parmeswarappa DC, Padhi TR, Subbarao B, Jalali S. Evaluation of optical coherence tomography biomarkers to differentiate favourable and unfavourable responders to intravitreal anti-vascular endothelial growth factor treatment in retinopathy of prematurity. Eye (London) 2023. https://doi.org/10.1038/s41433-023-02824-1

Mangalesh S, McGeehan B, Tai V, Chen X, Tran-Viet D, Vajzovic L. Study of Eye Imaging in Preterm Infants Group et al. Macular OCT characteristics at 36 weeks’ postmenstrual age in infants examined for retinopathy of prematurity. Ophthalmol Retin. 2021;5:580–92.

Article  Google Scholar 

Michalak SM, Mangalesh S, Chen Y, Shen LL, Tai V, Winter K. BabySTEPS Group et al. Longitudinal choroidal development in preterm infants. Ophthalmol Sci. 2023;4:100359.

Article  PubMed  PubMed Central  Google Scholar 

Vinekar A, Avadhani K, Sivakumar M, Mahendradas P, Kurian M, Braganza S, et al. Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Investig Ophthalmol Vis Sci. 2011;52:5183–8.

Article  Google Scholar 

Vinekar A, Nair AP, Sinha S, Vaidya T, Chakrabarty K, Shetty R, et al. Tear fluid angiogenic factors: potential noninvasive biomarkers for retinopathy of prematurity screening in preterm infants. Investig Ophthalmol Vis Sci. 2021;62:2.

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif